IDH2R140Q-IN-2

Modify Date: 2024-03-14 17:27:10

IDH2R140Q-IN-2 Structure
IDH2R140Q-IN-2 structure
Common Name IDH2R140Q-IN-2
CAS Number 2749568-16-7 Molecular Weight 484.40
Density N/A Boiling Point N/A
Molecular Formula C21H18F6N6O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of IDH2R140Q-IN-2


IDH2R140Q-IN-2 (compound 36) is an an orally active IDH2R140Q inhibitor (IC50: 29 nM). IDH2R140Q-IN-2 reduces D2HG production in TF-1 cell lines expressing mutant IDH2R140Q (IC50: 10 nM). IDH2R140Q-IN-2 suppresses D2HG levels in tumor tissue. IDH2R140Q-IN-2 can be used for research of acute myeloid leukemia (AML)[1].

 Names

Name IDH2R140Q-IN-2

 IDH2R140Q-IN-2 Biological Activity

Description IDH2R140Q-IN-2 (compound 36) is an an orally active IDH2R140Q inhibitor (IC50: 29 nM). IDH2R140Q-IN-2 reduces D2HG production in TF-1 cell lines expressing mutant IDH2R140Q (IC50: 10 nM). IDH2R140Q-IN-2 suppresses D2HG levels in tumor tissue. IDH2R140Q-IN-2 can be used for research of acute myeloid leukemia (AML)[1].
Related Catalog
References

[1]. Wei Q, et al. Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia. J Med Chem. 2023 Sep 28;66(18):12894-12910.  

 Chemical & Physical Properties

Molecular Formula C21H18F6N6O
Molecular Weight 484.40
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.